Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK)
Shanghai, CN
Shanghai Chicmax Cosmetic Co., Ltd. is a multifaceted beauty corporation based in China, specializing in the entire product lifecycle—from innovation and production to market distribution—for skincare, as well as maternity and infant care lines. The company provides an extensive array of cosmetic goods, including specialized serums, moisturizing lotions, hair cleansers, and facial treatments, alongside various other dermatological and trichological solutions. These offerings are presented through a broad spectrum of brands such as KANS, One Leaf, Baby Elephant, BIO-G, asnami, KYOCA, newpage, ARMIYO, and TAZU. Furthermore, the firm actively oversees its supply chain management operations. Established in 2003 and headquartered in Shanghai, People's Republic of China, the company underwent a rebranding in 2020, transitioning from its former identity as Shanghai Kaka Cosmetic Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.09% | -11.75% | -22.64% | -39.70% | -58.23% | -50.05% | -44.57% | +42.31% | +44.29% | +44.29% | +44.29% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 9 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+35.1% ★ Q4'25: +94.7% (vs Q4'23)
-
EPS growth Household & Personal Products: +8.8%+41.3% ★ Q4'25: +61.1% (vs Q4'23)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+6.5% ★ Q4'25: +8.6% (vs Q4'23)
-
EBIT margin Household & Personal Products: +9.9%+11.7% ★ Q4'25: +11.5% (vs Q4'23)
-
ROIC Household & Personal Products: +8.2%+34.7% ★ Q4'25: +74.7% (vs Q4'23)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.52× Q4'25: 0.24× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 9 Rev. Ana. 7 EPS Ana. |
Dec 2027 9 Rev. Ana. 7 EPS Ana. |
Dec 2028 3 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
2.68B
est: 2.66B (+0.5%)
|
4.19B
est: 4.08B (+2.8%)
|
6.79B
est: 6.85B (-0.8%)
|
9.18B
est: 8.94B (+2.7%)
|
11.55B
11.14B – 11.94B
+29.2% YoY
|
13.84B
12.82B – 14.59B
+19.8% YoY
|
16.32B
15.40B – 17.05B
+17.9% YoY
|
| EBITDA |
268.88M
est: 331.74M (-18.9%)
|
676.04M
est: 508.06M (+33.1%)
|
752.09M
est: 843.22M (-10.8%)
|
1.21B
est: 1.10B (+9.5%)
|
1.42B
1.37B – 1.47B
+29.2% YoY
|
1.70B
1.58B – 1.80B
+19.8% YoY
|
2.01B
1.90B – 2.10B
+17.9% YoY
|
| EBIT |
174.71M
est: 275.39M (-36.6%)
|
575.44M
est: 421.76M (+36.4%)
|
683.49M
est: 704.64M (-3.0%)
|
1.07B
est: 919.62M (+16.3%)
|
1.19B
1.15B – 1.23B
+29.2% YoY
|
1.42B
1.32B – 1.50B
+19.8% YoY
|
1.68B
1.58B – 1.75B
+17.9% YoY
|
| Net Income |
147.10M
est: 133.21M (+10.4%)
|
461.10M
est: 441.01M (+4.6%)
|
781.21M
est: 794.48M (-1.7%)
|
1.10B
est: 1.14B (-3.0%)
|
1.40B
1.34B – 1.47B
+23.2% YoY
|
1.69B
1.59B – 1.76B
+20.5% YoY
|
2.00B
1.86B – 2.12B
+18.7% YoY
|
| SGA |
1.48B
est: 1.53B (-3.5%)
|
2.45B
est: 2.35B (+4.3%)
|
4.19B
est: 3.95B (+6.1%)
|
5.69B
est: 5.15B (+10.5%)
|
6.66B
6.42B – 6.88B
+29.2% YoY
|
7.98B
7.39B – 8.41B
+19.8% YoY
|
9.41B
8.88B – 9.83B
+17.9% YoY
|
| EPS |
0.41
est: 0.33 (+22.5%)
|
1.16
est: 1.11 (+4.7%)
|
1.96
est: 2.00 (-1.8%)
|
2.77
est: 2.85 (-3.0%)
|
3.52
3.37 – 3.70
+23.2% YoY
|
4.24
3.99 – 4.43
+20.5% YoY
|
5.03
4.67 – 5.32
+18.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI China Small-Cap ETF ECNS | 0.16% | 105.0K | 0.59% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.03% | 33.0K | 0.42% |
| 3 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.02% | 439.4K | 0.58% |
| 4 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.02% | 16.6K | 0.74% |
| 5 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 52.8K | 0.74% |
| 6 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.01% | 54.6K | 0.72% |
| 7 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.01% | 70.4K | 0.55% |
| 8 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.25M | 0.06% |
| 9 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.01% | 16.6K | 0.33% |
| 10 | Amundi Prime Emerging Markets UCITS ETF DR (C) PRAM.L | 0.00% | 55.5K | 0.10% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yan Luo | Deputy Chief Executive Officer, GM of KANS Brand & Executive Director | 2M | female |
| Yifeng Feng | Deputy Chief Executive Officer, Chief Financial Officer & Executive Director | 2M | male |
| Yang Song | Executive Director, Deputy Chief Executive Officer & GM of One Leaf Brand Division | 1M | female |
| Yixiong Lyu | Chairman & Chief Executive Officer | 1M | male |
| Hao Sun | Secretary to the Board & Employee Representative Director | — | male |
| Wei Zhou | Chief Strategy Officer & Executive Director | — | female |
| Kin Wai Li | Joint Company Secretary | — | male |
| Tao Li | Chairman of the Supervisory Committee & Audit Director | — | male |
| Wei Li | Head of Global R&D Center and Vice President | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2145.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
